The oncology space, worth billions, continues to see intense investor interest, especially as companies explore biomarker-driven therapies. The News: Purple Biotech unveiled final Phase 2 results ...

Papua New Guinea is undergoing economic and social transformation. It is one of the most diverse countries in the world; home to over 11.78 million people and more than 800 different languages spoken ...

Summary: Researchers have identified a brain biomarker that may predict psychosis onset before symptoms appear, enabling earlier interventions and personalized care. MRI scans revealed abnormal ...

1Department of Radiology, Washington University School of Medicine, St. Louis, Missouri. 2Department of Surgery, Washington University School of Medicine, St. Louis, Missouri. 3Department of ...

Nielsen, Jr., Research Professor of Parkinson's Disease and Movement Disorders, have defined new biologic and clinical biomarkers for better identifying patients with different stages of Parkinson ...

Researchers are pointing toward a potential biomarker in the brain that could lead to more timely interventions and personalized care. The current standard of care for psychosis is a diagnostic ...

Researchers at the Del Monte Institute for Neuroscience at the University of Rochester are pointing toward a potential biomarker in the brain that could lead to more timely interventions and ...

(NASDAQ: CGTX), a clinical-stage company developing drugs to treat neurodegenerative disorders, provided an update on a biomarker 1 analysis from the Phase 2 ‘SHINE’ study in mild-to-moderate ...

A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathological processes, or a response to a therapeutic intervention.

Introduction: Osteoarthritis (OA) is a prevalent joint disease that severely impacts patients’ quality of life. Due to its unclear pathogenesis and lack of effective therapeutic targets, discovering ...